CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Share-based Payment Arrangement, Expense, Tax Benefit
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Share-based Payment Arrangement, Expense, Tax Benefit of $11.08 million for the 12-month period ending 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2026-02-18
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2021-12-25 was $2.69M, a 29.24% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2021-09-25 was $3.15M, a 25.80% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2021-06-26 was $2.46M, a 23.99% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2021-03-27 was $1.99M, a 28.11% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense, tax benefit for fiscal 2025 was $11.08M, a 5.68% increase from fiscal 2024.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense, tax benefit for fiscal 2024 was $10.49M, a 3.85% decline from fiscal 2023.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense, tax benefit for fiscal 2023 was $10.91M, a 0.57% decline from fiscal 2022.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense, tax benefit for fiscal 2022 was $10.97M, a 6.51% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 3 month | Share-based Payment Arrangement, Expense, Tax Benefit 6 month | Share-based Payment Arrangement, Expense, Tax Benefit 9 month | Share-based Payment Arrangement, Expense, Tax Benefit 12 month |
|---|---|---|---|---|
| 2025-12-27 | $11.08M 10-K · filed 2026-02-18 | |||
| 2024-12-28 | $10.49M 10-K · filed 2026-02-18 | |||
| 2023-12-30 | $10.91M 10-K · filed 2026-02-18 | |||
| 2022-12-31 | $10.97M 10-K · filed 2025-02-19 | |||
| 2021-12-25 | $2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $5.85M derived: sum of 2 quarters · filed 2024-02-14 | $8.31M derived: sum of 3 quarters · filed 2024-02-14 | $10.30M 10-K · filed 2024-02-14 |
| 2021-09-25 | $3.15M 10-Q · filed 2021-11-03 | $5.62M derived: sum of 2 quarters · filed 2021-11-03 | $7.61M 10-Q · filed 2021-11-03 | $9.69M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-26 | $2.46M 10-Q · filed 2021-08-04 | $4.45M 10-Q · filed 2021-08-04 | $6.54M derived: sum of 3 quarters · filed 2023-02-22 | $9.04M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-27 | $1.99M 10-Q · filed 2021-05-04 | $4.07M derived: sum of 2 quarters · filed 2023-02-22 | $6.58M derived: sum of 3 quarters · filed 2023-02-22 | $8.57M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-26 | $2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $4.59M derived: sum of 2 quarters · filed 2023-02-22 | $6.58M derived: sum of 3 quarters · filed 2023-02-22 | $8.13M 10-K · filed 2023-02-22 |
| 2020-09-26 | $2.51M 10-Q · filed 2021-11-03 | $4.50M derived: sum of 2 quarters · filed 2021-11-03 | $6.05M 10-Q · filed 2021-11-03 | $8.44M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-27 | $1.99M 10-Q · filed 2021-08-04 | $3.54M 10-Q · filed 2021-08-04 | $5.94M derived: sum of 3 quarters · filed 2022-02-16 | $8.10M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-28 | $1.55M 10-Q · filed 2021-05-04 | $3.95M derived: sum of 2 quarters · filed 2022-02-16 | $6.11M derived: sum of 3 quarters · filed 2022-02-16 | $8.97M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-28 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $4.56M derived: sum of 2 quarters · filed 2022-02-16 | $7.42M derived: sum of 3 quarters · filed 2022-02-16 | $9.46M 10-K · filed 2022-02-16 |
| 2019-09-28 | $2.17M 10-Q · filed 2020-10-29 | $5.02M derived: sum of 2 quarters · filed 2020-10-29 | $7.07M 10-Q · filed 2020-10-29 | $9.32M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-06-29 | $2.85M 10-Q · filed 2020-08-05 | $4.90M 10-Q · filed 2020-08-05 | $7.15M derived: sum of 3 quarters · filed 2021-02-17 | $9.52M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-03-30 | $2.05M 10-Q · filed 2020-05-07 | $4.29M derived: sum of 2 quarters · filed 2021-02-17 | $6.67M derived: sum of 3 quarters · filed 2021-02-17 | $9.12M derived: sum of 4 quarters · filed 2021-02-17 |
| 2018-12-29 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $4.62M derived: sum of 2 quarters · filed 2021-02-17 | $7.07M derived: sum of 3 quarters · filed 2021-02-17 | $9.19M 10-K · filed 2021-02-17 |
| 2018-09-29 | $2.37M 10-Q · filed 2019-11-06 | $4.82M derived: sum of 2 quarters · filed 2019-11-06 | $6.94M 10-Q · filed 2019-11-06 | $8.69M derived: sum of 4 quarters · filed 2020-02-11 |
| 2018-06-30 | $2.45M 10-Q · filed 2019-07-31 | $4.57M 10-Q · filed 2019-07-31 | $6.32M derived: sum of 3 quarters · filed 2020-02-11 | $10.41M derived: sum of 4 quarters · filed 2020-02-11 |
| 2018-03-31 | $2.12M 10-Q · filed 2019-05-07 | $3.86M derived: sum of 2 quarters · filed 2020-02-11 | $7.96M derived: sum of 3 quarters · filed 2020-02-11 | $12.24M derived: sum of 4 quarters · filed 2020-02-11 |
| 2017-12-30 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-11 | $5.84M derived: sum of 2 quarters · filed 2020-02-11 | $10.12M derived: sum of 3 quarters · filed 2020-02-11 | $13.43M 10-K · filed 2020-02-11 |
| 2017-09-30 | $4.10M 10-Q · filed 2017-11-09 | $8.38M derived: sum of 2 quarters · filed 2017-11-09 | $11.68M 10-Q · filed 2017-11-09 | $15.58M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-07-01 | $4.28M 10-Q · filed 2017-08-09 | $7.58M 10-Q · filed 2017-08-09 | $11.48M derived: sum of 3 quarters · filed 2019-02-13 | $15.26M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-04-01 | $3.31M 10-Q · filed 2017-05-10 | $7.20M derived: sum of 2 quarters · filed 2019-02-13 | $10.99M derived: sum of 3 quarters · filed 2019-02-13 | $15.34M derived: sum of 4 quarters · filed 2019-02-13 |
| 2016-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $7.68M derived: sum of 2 quarters · filed 2019-02-13 | $12.03M derived: sum of 3 quarters · filed 2019-02-13 | $15.55M 10-K · filed 2019-02-13 |
| 2016-09-24 | $3.79M 10-Q · filed 2017-11-09 | $8.14M derived: sum of 2 quarters · filed 2017-11-09 | $11.65M 10-Q · filed 2017-11-09 | $15.14M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-25 | $4.35M 10-Q · filed 2017-08-09 | $7.87M 10-Q · filed 2017-08-09 | $11.36M derived: sum of 3 quarters · filed 2018-02-13 | $15.09M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-26 | $3.51M 10-Q · filed 2017-05-10 | $7.00M derived: sum of 2 quarters · filed 2018-02-13 | $10.73M derived: sum of 3 quarters · filed 2018-02-13 | $14.35M derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-26 | $3.49M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $7.22M derived: sum of 2 quarters · filed 2018-02-13 | $10.84M derived: sum of 3 quarters · filed 2018-02-13 | $14.22M 10-K · filed 2018-02-13 |
| 2015-09-26 | $3.73M 10-Q · filed 2016-11-02 | $7.35M derived: sum of 2 quarters · filed 2016-11-02 | $10.74M 10-Q · filed 2016-11-02 | $13.47M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-27 | $3.62M 10-Q · filed 2016-08-03 | $7.00M 10-Q · filed 2016-08-03 | $9.74M derived: sum of 3 quarters · filed 2017-02-14 | $12.68M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-28 | $3.38M 10-Q · filed 2016-05-04 | $6.12M derived: sum of 2 quarters · filed 2017-02-14 | $9.06M derived: sum of 3 quarters · filed 2017-02-14 | $12.03M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-27 | $2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $5.68M derived: sum of 2 quarters · filed 2017-02-14 | $8.64M derived: sum of 3 quarters · filed 2017-02-14 | $11.01M 10-K · filed 2017-02-14 |
| 2014-09-27 | $2.94M 10-Q · filed 2015-11-04 | $5.91M derived: sum of 2 quarters · filed 2015-11-04 | $8.27M 10-Q · filed 2015-11-04 | $10.51M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-28 | $2.96M 10-Q · filed 2015-07-30 | $5.33M 10-Q · filed 2015-07-30 | $7.56M derived: sum of 3 quarters · filed 2016-02-12 | $9.67M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-29 | $2.36M 10-Q · filed 2015-04-30 | $4.60M derived: sum of 2 quarters · filed 2016-02-12 | $6.70M derived: sum of 3 quarters · filed 2016-02-12 | $8.98M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-28 | $2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $4.34M derived: sum of 2 quarters · filed 2016-02-12 | $6.62M derived: sum of 3 quarters · filed 2016-02-12 | $8.66M 10-K · filed 2016-02-12 |
| 2013-09-28 | $2.10M 10-Q · filed 2014-10-30 | $4.38M derived: sum of 2 quarters · filed 2014-10-30 | $6.42M 10-Q · filed 2014-10-30 | $8.60M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-29 | $2.28M 10-Q · filed 2014-08-07 | $4.32M 10-Q · filed 2014-08-07 | $6.50M derived: sum of 3 quarters · filed 2015-02-17 | $8.34M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-30 | $2.04M 10-Q · filed 2014-04-30 | $4.22M derived: sum of 2 quarters · filed 2015-02-17 | $6.07M derived: sum of 3 quarters · filed 2015-02-17 | $7.95M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-29 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $4.03M derived: sum of 2 quarters · filed 2015-02-17 | $5.91M derived: sum of 3 quarters · filed 2015-02-17 | $7.79M 10-K · filed 2015-02-17 |
| 2012-09-29 | $1.85M 10-Q · filed 2013-10-30 | $3.73M derived: sum of 2 quarters · filed 2013-10-30 | $5.62M 10-Q · filed 2013-10-30 | $7.35M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | $1.88M 10-Q · filed 2013-07-31 | $3.77M 10-Q · filed 2013-07-31 | $5.50M derived: sum of 3 quarters · filed 2014-02-25 | $7.49M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | $1.88M 10-Q · filed 2013-05-08 | $3.62M derived: sum of 2 quarters · filed 2014-02-25 | $5.61M derived: sum of 3 quarters · filed 2014-02-25 | $7.55M derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $3.73M derived: sum of 2 quarters · filed 2014-02-25 | $5.67M derived: sum of 3 quarters · filed 2014-02-25 | $7.78M 10-K · filed 2014-02-25 |
| 2011-09-24 | $1.99M 10-Q · filed 2012-11-01 | $3.93M derived: sum of 2 quarters · filed 2012-11-01 | $6.05M 10-Q · filed 2012-11-01 | $7.47M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-25 | $1.94M 10-Q · filed 2012-08-07 | $4.06M 10-Q · filed 2012-08-07 | $5.48M derived: sum of 3 quarters · filed 2013-02-27 | $7.92M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-26 | $2.12M 10-Q · filed 2012-05-04 | $3.54M derived: sum of 2 quarters · filed 2013-02-27 | $5.98M derived: sum of 3 quarters · filed 2013-02-27 | $8.78M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-25 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $3.86M derived: sum of 2 quarters · filed 2013-02-27 | $6.66M derived: sum of 3 quarters · filed 2013-02-27 | $9.18M 10-K · filed 2013-02-27 |
| 2010-09-25 | $2.44M 10-Q · filed 2011-11-02 | $5.25M derived: sum of 2 quarters · filed 2011-11-02 | $7.76M 10-Q · filed 2011-11-02 | |
| 2010-06-26 | $2.80M 10-Q · filed 2011-08-03 | $5.28M 10-Q · filed 2011-08-03 | ||
| 2009-12-26 | $8.39M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |